Clinical trials
Diabetes Mellitus clinical trials
Below are recruiting diabetes mellitus clinical trials, each written for real people, not researchers. We’re tracking 886 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06964620RecruitingEarly Phase 1
Sanggua Tablets for prediabetes and mild type 2 diabetes
This trial tests whether Sanggua Tablets, an herbal medicine, can help people with prediabetes or mild type 2 diabetes improve their blood sugar control without needing other medications.
Wuhan, HubeiAges 18–70 - NCT07007676Recruiting
Continuous glucose monitor for older adults with type 2 diabetes
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
Shenzhen, GuandongAges 60 years+ - NCT07059377RecruitingPhase 3
Semaglutide to help smokers with diabetes quit
This study tests if the diabetes drug semaglutide can help people with type 2 diabetes stop smoking more easily. Participants will get either semaglutide or a placebo to see if it improves quit rates.
Ottawa, OntarioAges 18 years+ - NCT07079189Recruiting
Digital lifestyle tool for type 2 diabetes
This trial tests a digital lifestyle tool combined with a smart chatbot to help people with type 2 diabetes improve their blood sugar control. It's a home-based program that gives personalized advice and support.
Malmö, Skåne CountyAges 35 years+ - NCT07091318RecruitingEarly Phase 1
CBT for insomnia in type 1 diabetes
This study tests whether cognitive behavioral therapy for insomnia (CBTi) can improve sleep in people with type 1 diabetes. It may help those who have poor sleep quality and use a continuous glucose monitor.
Chicago, IllinoisAges 18–65 - NCT07126873RecruitingPhase 1/Phase 2
Study of E-islet 01 for type 1 diabetes with severe low blood sugar
This study tests a new treatment called E-islet 01, which may help people with type 1 diabetes who have very low natural insulin production and have had dangerous low blood sugar events. The goal is to see if it is safe and can reduce those episodes.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07245082Recruiting
Type 2 diabetes patient study
This study looks at people with type 2 diabetes to understand their health. If you join, you'll have simple measurements taken like height, weight, and grip strength.
Taipei, Zhongzheng DistAges 18 years+ - NCT07270016Recruiting
Real-time support for young adults with type 2 diabetes
This trial tests an app designed to help young people manage their type 2 diabetes. It uses real-time feedback to improve blood sugar control and build healthy habits.
Pittsburgh, PennsylvaniaAges 16–24 - NCT07307183Recruiting
Predicting foot ulcers risk in diabetes
This study is developing a tool to predict your risk of getting foot ulcers if you have diabetes. By analyzing medical records, the researchers hope to identify people who need extra prevention and care.
JonseredAges 18 years+ - NCT07361640Recruiting
E-health lifestyle program for type 2 diabetes
This trial tests a smartphone-based lifestyle program to help people with newly diagnosed type 2 diabetes lose weight and improve blood sugar control. You'll get a digital program with coaching and support, instead of usual care alone.
OsloAges 18 years+ - NCT00948116Recruiting
Blood and urine tests to predict kidney injury in diabetes
This study checks whether a set of blood and urine tests can predict “acute kidney injury” (a sudden worsening of kidney function) earlier in people with diabetes who are undergoing a heart procedure. If the tests work, they may help doctors spot kidney trouble sooner and protect your kidneys.
LondonAges 18 years+ - NCT01630850Recruiting
Islet cell transplant for brittle type 1 diabetes
This trial studies whether transplanting insulin-producing islet cells can improve blood sugar control and reduce severe low blood sugar in people with “brittle” type 1 diabetes. It’s meant for adults with long-standing insulin dependence and troublesome, hard-to-control hypoglycemia.
Chicago, IllinoisAges 18–70 - NCT01511393Enrolling by invitation
Tracking people with thyroid cancer to learn its course
This study follows adults who have medullary thyroid cancer (MTC) to learn how the cancer behaves over time. It may help by improving future care and follow-up strategies for people with MTC.
Morgantown, West VirginiaAges 18 years+ - NCT07415954RecruitingPhase 2
Testing a new diabetes medicine for blood sugar control
This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.
Lancaster, CaliforniaAges 18–75 - NCT07076199RecruitingPhase 3
Weekly vs daily insulin for type 1 diabetes
This study tests a new once-weekly insulin (icodec) against a standard daily insulin (glargine), both taken with mealtime insulin. It aims to see which works better to control blood sugar in adults with type 1 diabetes.
Cullman, AlabamaAges 18 years+ - NCT07487467Recruiting
Stem cell therapy for type 2 diabetes
This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.
São Jose Do Rio Preto, São PauloAges 18 years+ - NCT07535307RecruitingPhase 1
Testing NNC0487-0111 to regulate insulin in type 2 diabetes
This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.
NeussAges 18–75 - NCT07552389RecruitingPhase 3
Blood Pressure and Diabetes Combination Drug Trial
This study tests whether taking two separate blood pressure medications work as well as taking them combined in one pill for people with high blood pressure and type 2 diabetes. The goal is to find the best, safest way to treat both conditions together.
SeoulAges 19 years+ - NCT07642830Enrolling by invitation
Digital Health Tools for Type 2 Diabetes Management
This study tests a smartphone-based digital health system designed to help people with type 2 diabetes manage their condition better. The program uses technology on your phone to support your diabetes care over time.
Taoyuan, TaiwanAges 20–75 - NCT07289204Enrolling by invitation
How Aging Affects People with Type 1 Diabetes
This trial looks at how aging affects people with type 1 diabetes. It is for older adults who are already in a major Finnish diabetes study to help understand health changes over time.
HelsinkiAges 65 years+ - NCT07118475Enrolling by invitationEarly Phase 1
Islet transplant for type 2 diabetes
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
ShanghaiAges 18–75 - NCT07019649Enrolling by invitation
AYUDA program for younger Latinx adults with type 2 diabetes
This study tests a program called AYUDA, which sends helpful text messages and support to younger Latinx adults (ages 18–44) who were recently diagnosed with type 2 diabetes and are raising children. The goal is to see if this program helps manage diabetes better.
Pleasanton, CaliforniaAges 18–44 - NCT06895018Enrolling by invitation
Grape Drink Trial for Diabetes and Fatty Liver
This study tests a drink made from grape pomace (a natural byproduct) that is rich in polyphenols—compounds that may help the liver and heart. Participants have type 2 diabetes and mild fatty liver, and researchers want to see if the drink improves liver health, blood sugar, and gut bacteria over several months.
NaplesAges 35–70 - NCT06517576Enrolling by invitation
Remote monitoring for type 2 diabetes
This trial tests using a smartphone to help manage your blood sugar. It's for people with type 2 diabetes who take insulin and whose blood sugar is not well controlled (HbA1c 8% or higher).
Chicago, IllinoisAges 18 years+
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes mellitus?
- Yes. Clin2 currently lists 886 recruiting diabetes mellitus studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes mellitus trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes mellitus trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.